5:17 PM
 | 
Jun 26, 2012
 |  BC Extra  |  Company News

Roche declines SYN120 option

Biotie Therapies Corp. (HSE:BTH1V) said Roche (SIX:ROG; OTCQX:RHHBY) declined to exercise its option to regain rights to cognitive impairment product SYN120, citing...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >